In vitro metabolism of clindamycin in human liver and intestinal microsomes.
about
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolismAntibiotic treatment for the sexual partners of women with bacterial vaginosisUse of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsPharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malariaDevelopment of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data.Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionA comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine.Clindamycin Pharmacokinetics and Safety in Preterm and Term InfantsUpdate on clindamycin in the management of bacterial, fungal and protozoal infections.Treatment of prosthetic joint infections due to Propionibacterium. Similar results in 60 patients treated with and without rifampicin.Interethnic differences in pharmacokinetics of antibacterials.The discovery of methionine sulfoxide reductase enzymes: An historical account and future perspectives.Antibiotic treatment for the sexual partners of women with bacterial vaginosis.Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.Interaction between tacrolimus and clindamycin.Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes.Determination of clindamycin and its metabolite clindamycin sulfoxide in diverse sewage samples.HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.Extrahepatic Drug-Metabolizing Enzymes and Their Significance
P2860
Q22251223-8D12A7B3-542A-4DFE-84D9-21F5BD99FA9DQ24188259-B4298442-8CD4-4CCC-BD23-E32ACC5EA36DQ30832465-EED381A3-DD74-4887-8D9C-FDC0E97F18F7Q35850868-1E9977DA-0C9D-4260-911E-73716B353642Q36307045-5EE18A90-C957-4A7E-9610-111B3E3D0158Q36320042-66139612-868E-4A3B-BE98-1DAE59CB299FQ36331220-8CE0FBC3-D810-443C-B580-049A3CEA5B8FQ36887756-099966B9-DC79-42BD-9131-7888613A0815Q36967293-8D66A5B7-AEFA-4E25-A0D6-7C6E44F2F1C9Q37084442-6DF9E52D-3663-4C63-999A-F839B31A4ACFQ38266806-CFFAF9FB-4EE7-4B56-93DF-9EA1A20EDB6DQ38473835-E4469D1C-C32A-43F9-AEDC-872516651F57Q38970652-366229DA-92BE-4632-AD8C-EDE744B30FA7Q39660163-42167A40-E91D-4844-8D9B-F28B6D6BA0E0Q40332988-854C15CE-5997-4FB4-9945-E26F66E34BF5Q41359629-8302D7E3-CB19-4886-B261-4AB7E7FD71D2Q41986693-A5522AF8-2DA1-4916-8479-081EFAD6F37EQ42227266-4926D9AA-4B06-43E7-BF2F-5BC2809BB52AQ43309876-0B6AEC68-5F2F-4935-810C-295E77D9A195Q51199177-057B3144-E4E2-43F4-8785-47C10C799D3CQ57258718-35AB6565-3717-4C20-AB10-D68EDBA12BC2
P2860
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@en
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@nl
type
label
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@en
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@nl
prefLabel
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@en
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@nl
P2093
P356
P1476
In vitro metabolism of clindamycin in human liver and intestinal microsomes.
@en
P2093
J Matthew Hutzler
Larry C Wienkers
Michael A Wynalda
Michael D Koets
Terry Podoll
P304
P356
10.1124/DMD.31.7.878
P577
2003-07-01T00:00:00Z